Literature DB >> 19848210

[Clinical observation of Flos magnoliae volatile oil nano-liposome nasal drops in treating pediatric allergic rhinitis].

Min Wu1, Jing-Yan Zhang, Xin Zhang.   

Abstract

OBJECTIVE: To observe the clinical efficacy of Flos Magnoliae volatile oil nano-liposome nasal drops (FMO) in treating pediatric allergic rhinitis (PAR).
METHODS: Adopting parallel controlled method, the 191 patients with PAR were randomized into two groups. The observation group was treated with FMO, and the control group with Cetirizine. The clinical efficacy, main symptoms, signs, syndromes scores of Chinese medicine, and peripheral eosinophil (EOS) count were observed after 3-week treatment.
RESULTS: In the observation group, the total effective rate was 94.84%, which was higher than that in the control group (78.72%); the effective rate on alleviating main symptoms (sneezing, nasal obstruction), signs (nasal mucosa edema, pallor) and the EOS count were significantly lowered, all were better than those in the control group (P <0.05).
CONCLUSION: FMO has some positive effects on PAR, it might be realized by lowering the peripheral EOS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19848210

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Anti-Inflammatory Food in Asthma Prepared from Combination of Raphanus sativus L., Allium hookeri, Acanthopanax sessiliflorum, and Dendropanax morbiferus Extracts via Bioassay-Guided Selection.

Authors:  Kyung-Dong Lee; Sun-Yup Shim
Journal:  Foods       Date:  2022-06-27

2.  Preparation and quality evaluation of a volatile oil microemulsion from Flos magnoliae and Centipeda minima.

Authors:  Yulin Liang; Junbo Zou; Xiaofei Zhang; Yajun Shi; Jia Tai; Yu Wang; Dongyan Guo; Ming Yang
Journal:  Mol Med Rep       Date:  2020-10-08       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.